CEP
REGN icon

Chicago Equity Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Chicago Equity Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1.27M Buy
+2,605
New +$1.07M 0.13% 237
2019
Q2 		– Sell
-7,170
Closed -$2.94M – 962
2019
Q1 		$2.94M Buy
7,170
+442
+7% +$182K 0.11% 244
2018
Q4 		$2.51M Sell
6,728
-3,945
-37% -$1.44M 0.1% 285
2018
Q3 		$4.31M Buy
10,673
+118
+1% +$44.9K 0.13% 223
2018
Q2 		$3.64M Buy
10,555
+4,460
+73% +$1.39M 0.11% 271
2018
Q1 		$2.1M Buy
6,095
+4,425
+265% +$1.54M 0.07% 365
2017
Q4 		$628K Buy
1,670
+160
+11% +$64.8K 0.02% 576
2017
Q3 		$675K Buy
+1,510
New +$719K 0.02% 579
2016
Q1 		– Sell
-1,270
Closed -$689K – 646
2015
Q4 		$689K Buy
1,270
+365
+40% +$198K 0.02% 427
2015
Q3 		$421K Buy
+905
New +$486K 0.01% 488
2014
Q1 		– Sell
-1,500
Closed -$412K – 478
2013
Q4 		$412K Buy
1,500
+25
+2% +$7.19K 0.01% 324
2013
Q3 		$461K Sell
1,475
-95
-6% -$25K 0.01% 347
2013
Q2 		$353K Buy
+1,570
New +$366K 0.01% 366

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Chicago Equity Partners's REGN Position: Q1 2020 in Review

Chicago Equity Partners opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2020: 2,605 shares worth $1.27M. The stake represents 0.13% of the portfolio and ranks #237 among its holdings. This is a return to the name: Chicago Equity Partners previously reported a position in REGN as recently as Q1 2019.

Chicago Equity Partners first reported a position in REGN in Q2 2013 and has held it in 13 quarters since. The position peaked at $4.31M in Q3 2018. 816 funds tracked by Wall St. Rank hold REGN as of Q1 2020.

  • Chicago Equity Partners held 2,605 shares of Regeneron Pharmaceuticals worth $1.27M as of Q1 2020.
  • Regeneron Pharmaceuticals was a new Chicago Equity Partners position in Q1 2020.
  • Regeneron Pharmaceuticals made up 0.13% of Chicago Equity Partners's portfolio in Q1 2020, its #237 holding.
  • Chicago Equity Partners first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
  • Chicago Equity Partners's Regeneron Pharmaceuticals position peaked at $4.31M in Q3 2018.
  • 816 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.